{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:19:32Z","timestamp":1755037172079},"reference-count":10,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,14]]},"DOI":"10.1182\/blood-2011-04-347328","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T17:14:56Z","timestamp":1310663696000},"page":"474-476","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease"],"prefix":"10.1182","volume":"118","author":[{"given":"Jon D.","family":"Blumenfeld","sequence":"first","affiliation":[{"name":"The Rogosin Institute and the Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Tepler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mauer","sequence":"additional","affiliation":[{"name":"The Rockefeller University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Coller","sequence":"additional","affiliation":[{"name":"The Rockefeller University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Bichet","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Physiology, University of Montreal, H\u00f4pital du Sacr\u00e9-Coeur, Montr\u00e9al, QC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Smith","sequence":"additional","affiliation":[{"name":"The Rogosin Institute and the Department of Surgery, Weill Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"1","key":"2019111806380912400_B1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111806380912400_B2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"2019111806380912400_B3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease.","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2019111806380912400_B4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","article-title":"Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study.","volume":"57","author":"Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2019111806380912400_B5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2010.01.013","article-title":"Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.","volume":"56","author":"Rozen-Zvi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2019111806380912400_B6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1538-7836.2010.04105.x","article-title":"Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.","volume":"9","author":"Mauer","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111806380912400_B7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21405","article-title":"Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI\/NIH guidelines.","volume":"84","author":"Nichols","year":"2009","journal-title":"Am J Hematol"},{"issue":"6","key":"2019111806380912400_B8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease.","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"14","key":"2019111806380912400_B9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198804073181403","article-title":"Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.","volume":"318","author":"Bichet","year":"1988","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111806380912400_B10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease.","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/474\/1343804\/zh802811000474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/474\/1343804\/zh802811000474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:38:24Z","timestamp":1574077104000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/2\/474\/28507\/Tolvaptan-inhibition-of-desmopressin-effects-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-347328","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}